Cargando…
Case Study - Candida auris in Skilled Nursing Facility
Candida Auris (C. auris), is a multidrug-resistant organism, first described in Japan 2009, and now a serious, emerging global health threat1. C. auris pathogen can potentiate morbidity and mortality, i.e. lifelong contact precaution isolation, intravenous antifungal treatment, hospitalization and m...
Autores principales: | Vo, Nancy, Tokumitsu, Sayaka, Melik-Abramians, Armen, John, S Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681536/ http://dx.doi.org/10.1093/geroni/igab046.2340 |
Ejemplares similares
-
Candida auris in skilled nursing facilities
por: Yune, Philip S., et al.
Publicado: (2023) -
1268. Transmissibility of Candida auris by Type of Inpatient Healthcare Facility
por: Paul, Prabasaj, et al.
Publicado: (2018) -
378. Candida auris Fungemia: Risk Factors and Outcome
por: Adam, Rodney, et al.
Publicado: (2018) -
2474. Emergence of Candida auris in Michigan
por: McNamara, Sara E, et al.
Publicado: (2023) -
897. Prevalence of Candida auris at Body Sites, Characterization of Skin Microbiota, and Relation of Chlorhexidine Gluconate (CHG) Skin Concentration to C. auris Detection Among Patients at a High-Prevalence Ventilator-Capable Skilled Nursing Facility (vSNF) with Established CHG Bathing
por: Hayden, Mary K, et al.
Publicado: (2019)